Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Krahn

Showing results (41-50 of 62) with videos related to

Pageof 7
Sort By:
Journal of Molecular and Cellular Cardiology|July 17, 2007
Protein kinase C protects preconditioned rabbit hearts by increasing sensitivity of adenosine A2b-dependent signaling during early reperfusionAtsushi Kuno, Stuart D Critz, Lin Cui, et al.
Chemmedchem|August 8, 2006
Selective indole-based ECE inhibitors: synthesis and pharmacological evaluationMichael Brands, Jens-Kerim Ergüden, Kentaro Hashimoto, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|May 28, 2008
Plasma biomarkers of myocardial fibrosis and remodeling in terminal heart failure patients supported by mechanical circulatory support devicesHendrik Milting, Peter Ellinghaus, Michael Seewald, et al.
Circulation|March 14, 2007
Cardioprotection by ecto-5'-nucleotidase (CD73) and A2B adenosine receptorsTobias Eckle, Thomas Krahn, Almut Grenz, et al.
The Journal of Infectious Diseases|April 7, 2020
Nonalcoholic Fatty Liver Disease and the Development of Metabolic Comorbid Conditions in Patients With Human Immunodeficiency Virus InfectionThomas Krahn, Myriam Martel, Ruth Sapir-Pichhadze, et al.
Cardiovascular Research|July 16, 2021
Cyclic GMP modulating drugs in cardiovascular diseases: mechanism-based network pharmacologyAlexandra Petraina, Cristian Nogales, Thomas Krahn, et al.
Stroke|July 10, 2020
High-Sensitivity Cardiac Troponin T for Risk Stratification in Patients With Embolic Stroke of Undetermined SourceJan F Scheitz, Guillaume Pare, Lesly A Pearce, et al.
Head & Neck|January 11, 2020
Hepatocyte Growth Factor Receptor overexpression predicts reduced survival but its targeting is not effective in unselected HNSCC patientsMartin Khan, Sami S Khaznadar, Johannes Routila, et al.
Vascular Medicine (London, England)|May 31, 2017
Reliability of peripheral arterial tonometry in patients with heart failure, diabetic nephropathy and arterial hypertensionFabian Weisrock, Max Fritschka, Sebastian Beckmann, et al.
Journal of Personalized Medicine|February 25, 2022
Two-Tier Care Pathways for Liver Fibrosis Associated to Non-Alcoholic Fatty Liver Disease in HIV Mono-Infected PatientsGiada Sebastiani, Jovana Milic, Adriana Cervo, et al.
Pageof 7

Showing results (41-50 of 62) with videos related to

Sort By:
Pageof 7
Journal of Molecular and Cellular Cardiology|July 17, 2007
Protein kinase C protects preconditioned rabbit hearts by increasing sensitivity of adenosine A2b-dependent signaling during early reperfusionAtsushi Kuno, Stuart D Critz, Lin Cui, et al.
Chemmedchem|August 8, 2006
Selective indole-based ECE inhibitors: synthesis and pharmacological evaluationMichael Brands, Jens-Kerim Ergüden, Kentaro Hashimoto, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|May 28, 2008
Plasma biomarkers of myocardial fibrosis and remodeling in terminal heart failure patients supported by mechanical circulatory support devicesHendrik Milting, Peter Ellinghaus, Michael Seewald, et al.
Circulation|March 14, 2007
Cardioprotection by ecto-5'-nucleotidase (CD73) and A2B adenosine receptorsTobias Eckle, Thomas Krahn, Almut Grenz, et al.
The Journal of Infectious Diseases|April 7, 2020
Nonalcoholic Fatty Liver Disease and the Development of Metabolic Comorbid Conditions in Patients With Human Immunodeficiency Virus InfectionThomas Krahn, Myriam Martel, Ruth Sapir-Pichhadze, et al.
Cardiovascular Research|July 16, 2021
Cyclic GMP modulating drugs in cardiovascular diseases: mechanism-based network pharmacologyAlexandra Petraina, Cristian Nogales, Thomas Krahn, et al.
Stroke|July 10, 2020
High-Sensitivity Cardiac Troponin T for Risk Stratification in Patients With Embolic Stroke of Undetermined SourceJan F Scheitz, Guillaume Pare, Lesly A Pearce, et al.
Head & Neck|January 11, 2020
Hepatocyte Growth Factor Receptor overexpression predicts reduced survival but its targeting is not effective in unselected HNSCC patientsMartin Khan, Sami S Khaznadar, Johannes Routila, et al.
Vascular Medicine (London, England)|May 31, 2017
Reliability of peripheral arterial tonometry in patients with heart failure, diabetic nephropathy and arterial hypertensionFabian Weisrock, Max Fritschka, Sebastian Beckmann, et al.
Journal of Personalized Medicine|February 25, 2022
Two-Tier Care Pathways for Liver Fibrosis Associated to Non-Alcoholic Fatty Liver Disease in HIV Mono-Infected PatientsGiada Sebastiani, Jovana Milic, Adriana Cervo, et al.
Pageof 7